Betrixaban
CAS: 330942-05-7
Ref. TM-T4341
2mg | 46.00 € | ||
5mg | 69.00 € | ||
10mg | 94.00 € | ||
25mg | 169.00 € | ||
50mg | 278.00 € | ||
100mg | 446.00 € | ||
500mg | 975.00 € | ||
1ml*10 (DMSO) | 76.00 € |
Product Information
- PRT054021
- Benzamide, N-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-
- Bevyxxa
- N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide
- Prt 054021
Betrixaban (PRT054021) is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity [3]. Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboembolism (VTE) prophylactic for adult patients with moderate to severe restricted motility or with other risks for VTE [2]. VTE can be manifested as deep vein thrombosis or pulmonary embolism and it is a leading cause of preventable death in hospitalized patients [4].
Chemical properties
Technical inquiry about: TM-T4341 Betrixaban
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.